News Headlines
- Greenphire Appoints Steve Geffon As Chief Commercial Officer 4/6/2023
- Phlexglobal Announces Industry-First eTMF AI 4/6/2023
- Kayentis Raises Further 5 Million Euros To Boost US Activities 3/30/2023
-
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
3/24/2023
Agilis is a trusted human factors partner for the global medical market. They specialize in helping new and established companies achieve successful HF submissions while navigating the complex global regulatory landscape, resulting in safe and effective medical products being brought to market.
- Stevanato Group Collaborates With Thermo Fisher Scientific To Bring Its Innovative On-Body Delivery System Platform To Market 3/23/2023
- Greenphire Launches Research Registry App 3/22/2023
-
PCI Pharma Services Expands Biologics Leadership With New Center Of Excellence Facility In The Midwest
3/15/2023
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules.
- Premier Research & InSilicoTrials Leverage Silico Modeling, Simulation, & Optimize Regulatory Pathways For Rare Disease Therapies 3/13/2023
-
Greenphire Expands Agreement With Merck To Help Reduce Financial And Travel Barriers For Clinical Trial Participants Worldwide
3/13/2023
Greenphire, the global leader in financial lifecycle management for clinical trials, today announced an expansion of its agreement with Merck, known as MSD outside the United States and Canada. This expanded agreement now includes the use of Greenphire’s ClinCard with rideshare integration for participants across Merck’s clinical development network.
- Greenphire’s ConneX Global Travel Solution Expands In-Country Support 3/2/2023